POSEDEL RHEA J 4

What Happened Rhea J. Posedel, a director of Aehr Test Systems (AEHR), sold 15,000 shares on April 16, 2026. The reported sale price was $80.72 per share, for a total transaction value of approximately $1,210,800. This was a sale (not a purchase), which is commonly routine insider liquidity rather than a direct signal of company outlook.

Key Details

• Transaction date: 2026-04-16; Price: $80.72 per share; Total proceeds: ~$1,210,800.
• Transaction type: Report lists "open market or private sale" (Form 4 sale, code S).
• Shares owned after transaction: Not specified in the information provided in this summary / not stated in the filing excerpt.
• Footnote: The filing notes the reported amount includes shares subject to unvested restricted stock units (RSUs).
• Filing timeliness: No late filing is indicated in the provided details.

Context Sales by directors can be routine (diversification, tax planning, etc.) and do not, by themselves, indicate management sentiment. The presence of unvested RSUs in the reported amount means part of the reported position may still be subject to vesting restrictions.